EVACVSPACB• 28 Days (Normalized)
EVAC vs PACB (EQV Ventures Acquisition Corp. II vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Sep 10 to Oct 8, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
EVAC Performance $10.31
+0%
EQV Ventures Acquisition Corp. II
Normalized Baseline0.00%
PACB Performance $2.72
+114.17%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-114.17 pts
PACB outperforming by 114.17 percentage points
EVACPACB
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
EVAC PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | EVAC Price | EVAC Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 07, 2026 | $10.31 | +0.00% | $2.72 | +114.17% | -114.17% |
| Oct 06, 2026 | $10.32 | +0.10% | $2.70 | +112.60% | -112.50% |
| Oct 05, 2026 | $10.32 | +0.10% | $2.87 | +125.98% | -125.88% |
| Oct 02, 2026 | $10.31 | +0.00% | $2.54 | +100.00% | -100.00% |
| Oct 01, 2026 | $10.31 | +0.00% | $2.51 | +97.64% | -97.64% |
| Sep 30, 2026 | $10.32 | +0.10% | $2.37 | +86.61% | -86.51% |
| Sep 29, 2026 | $10.31 | +0.00% | $1.83 | +44.09% | -44.09% |
| Sep 28, 2026 | $10.32 | +0.10% | $1.71 | +34.65% | -34.55% |
| Sep 25, 2026 | $10.31 | +0.00% | $- | - | |
| Sep 24, 2026 | $10.30 | -0.10% | $1.46 | +14.57% | -14.67% |
| Sep 23, 2026 | $10.31 | +0.00% | $1.41 | +11.02% | -11.02% |
| Sep 22, 2026 | $10.31 | -0.05% | $- | - | |
| Sep 21, 2026 | $10.30 | -0.10% | $1.36 | +7.09% | -7.19% |
| Sep 18, 2026 | $10.30 | -0.10% | $1.37 | +7.87% | -7.97% |
| Sep 17, 2026 | $10.30 | -0.10% | $1.38 | +8.66% | -8.76% |
Page 1 of 2